跳至主要内容
临床试验/NCT06622213
NCT06622213尚未招募2 期

Comparison of the Efficacy of Mucoadhesive Film with and Without Acmella Oleracea Extract and 0.1% Triamcinolone Acetonide for Treatment of Aphthous Ulcers: a Randomized Control Trial

Khon Kaen University0 个研究点目标入组 72 人开始时间: 2024年10月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
72
主要终点
Reduction of ulcer size after using product

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of mucoadhesive film with or without Acmella oleracea extract compared to standard treatment by using 0.1% triamcinolone acetonide in pain relief, promoting wound healing, healing time and satisfaction in 3 aspects included taste, product used and quality of life after using the product.

详细描述

Participants who consent and meet the inclusion criteria will be allocated into 3 groups using block randomization: group 1: mucoadhesive film with Acmella oleracea extract, group 2: 0.1% triamcinolone acetonide, and group 3: mucoadhesive film without Acmella oleracea extract.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessor will not know which treatment each participant will receive (single blinding). Participants will know the type of treatment they received.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy participants aged 18-50 years without any underlying diseases.
  • Participants are voluntary and have signed the informed consent.
  • Participants are literate.
  • Participants can follow the treatment guidelines and follow up.
  • Participants have one untreated oral ulcer lesion.
  • An ulcer has occurred within 48 hours.
  • The ulcer size is less than 10 mm.
  • The ulcer is clearly visible and located on non-keratinized oral mucosa such as buccal mucosa, labial mucosa, alveolar mucosa, or buccal vestibule.
  • The ulcer must be painful.
  • If an ulcer is caused by a denture or orthodontic appliance, the cause must be eliminated before participation.
  • Participants must not be currently participating in any other clinical studies about oral ulcer

排除标准

  • Participants with allergies to herbal extracts, Acmella oleracea, or steroids.
  • Participants with chronic underlying diseases.
  • Participants with underlying diseases that may affect wound healing.
  • Participants receiving anti-analgesic drug, systemic steroids, antibiotics, hormones, NSAIDS, or any drugs that affect the oral mucosa.
  • Oral ulcer lesion larger than 10 mm or lesions resembling herpetic form of aphthous ulcers.
  • Oral ulcers are caused by infection or associated with systemic diseases.
  • Participants with poor oral hygiene requiring emergency treatment.
  • Participants who smoke or consume alcohol regularly.
  • Participants who are pregnant, breastfeeding, or planning to become pregnant during the study period.

研究组 & 干预措施

mucoadhesive film with Acmella oleracea extract

Experimental

Participants received mucoadhesive film with Acmella oleracea extract.

干预措施: mucoadhesive film with Acmella oleracea extract (Other)

Triamcinolone acetonide

Active Comparator

Participants received 0.1% Triamcinolone acetonide.

干预措施: Triamcinolone Acetonide 0.1% Oromucosal Paste (Drug)

mucoadhesive film without Acmella oleracea extract

Placebo Comparator

Participants received mucoadhesive film without Acmella oleracea extract.

干预措施: mucoadhesive film without Acmella oleracea extract (Other)

结局指标

主要结局

Reduction of ulcer size after using product

时间窗: Base line, day4, day7, day10 and day 14

Reduction of ulcer size will be evaluated by measuring the diameter of ulcers size using a periodontal probe and photograph on the first day and each follow up visit.

Pain score

时间窗: Base line, day4, day7, day10 and day 14

The pain score will be assessed by using a visual analogue scale (VAS) which is a 10-cm line on that was labeled from \"no pain\"(0) to \"worst pain\" (10).The pain level will be recorded on the first day. The participants will then reassess their pain score again after receiving the intervention, which will be evaluated at each follow up visit.

次要结局

  • Satisfaction score(Day 14)
  • Quality of life score(base line and day 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kemporn Kitsahawong

Principle investigator

Khon Kaen University

相似试验